Healthcare

President Trump: Next Two Weeks Will Be Tough…’There Will Be A Lot Of Death’

Published

3 years ago

April 4, 2020

“This will probably be the toughest week — between this week and next week,” President Trump said Saturday during his briefing at the White House.

“There will be a lot of death, unfortunately. But a lot less death than if this wasn’t done,” President said of the nationwide precautions underway. “But there will be death.”

On April 4th, the number of Americans infected topped 300,000. Trump said he’s deploying 1,000 medical military personnel to New York, the epicenter of the United States outbreak.

Dr. Deborah Birx said the modeling shows that the three major hotspots the country in New York, Detroit and Louisiana will peak in the next six or seven days.

“We will move heaven and Earth to safeguard our great American citizens,” Trump said. “We will continue to use every power, every authority, every single resource we’ve got to keep our people healthy, safe, secure and to get this thing over with.”

“We want to finish this war. We have to get back to work.”

Related Topics:coronavirus Donald J. Trump

Click to comment

China

FDA will work with China to import cancer drugs due to U.S. shortages

Published

3 days ago

June 7, 2023

Sara Carter Staff

Earlier this week the United States Food and Drug Administration (FDA) announced it will be working to import chemotherapy drugs from, of all places, China. The drug, called Cisplatin, is to help “ramp up supply amidst rampant drug shortages in the U.S.” reports Foreign Desk News.

Foreign Desk News writes:

Cisplatin comes from drugmaker Qilu Pharmaceutical, which is marketed and produced in China but has not been approved by the FDA. According to a May 24 letter, Qilu will work with the Canadian-based drug company Apotex to import and distribute the medication, which will come in 50-milligram vials with Chinese labels.

“The FDA is responding to yet another generic drug shortage,” said Edmund F. Haislmaier, an expert in healthcare policy and markets at The Heritage Foundation. “The underlying cause of those shortages is that generic drugs have become low-margin commodity products,” he added.

Last week on Twitter, FDA commissioner Dr. Robert Califf said the partnership with Qilu Pharmaceutical is temporary but will provide patients with a potentially life-extending drug.

“The public should rest assured that we will continue all efforts within our authority to help the industry that manufactures and distributes these drugs meet all patient needs for the oncology drugs impacted by shortages,” Califf said.

The public should rest assured that we will continue all efforts within our authority to help the industry that manufactures and distributes these drugs meet all patient needs for the oncology drugs impacted by shortages. https://t.co/8XvOuJzSL4

— Dr. Robert M. Califf (@DrCaliff_FDA) June 3, 2023

Foreign Desk News adds:

The latest move by the FDA is sure to spark concern and debate in Congress, as lawmakers in the House and Senate have called on the Biden administration to de-couple the U.S. economy from the Chinese markets, given Beijing’s aggressive push to expand in the South-China Sea and eventually take over the island state of Taiwan. China has also spread illegal and dangerous synthetic opioids and fentanyl drugs across the U.S. southern border, resulting in the devastating deaths of many Americans.